{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:29:59Z","timestamp":1794328199812,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Life expectancy is increasing in the HIV-positive population and age-related non-communicable diseases, such as cardiovascular disease, (CVD) are seen more frequently. This study investigated to what extent HIV and antiretroviral therapy (ART) is associated with CVD risk in an urban African population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was performed in Johannesburg, South Africa, between July 2016 and November 2017. Both HIV-positive adults (ART-na\u00efve, or on first- or second-line ART), as well as age and sex matched HIV-negative controls who were family or friends of the HIV-positive participants were included. Data were collected on demographics, cardiovascular risk factors, HIV-related characteristics, carotid intima-media thickness (CIMT) and carotid distensibility. The association between HIV, ART and CIMT and distensibility was analysed with linear regression models, adjusting for age, gender and CVD risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 548 participants, 337 (62%) females, age 38.3\u2009\u00b1\u20099.5\u00a0years of whom 104 (19.0%) were HIV-positive, ART-na\u00efve; 94 (17.2%) were on first-line ART; 197 (35.9%) were on second-line ART; and 153 (27.9%) were HIV-negative. Participants on second-line ART had higher CIMT and lower distensibility compared to the other groups (p\u2009&lt;\u20090.001). After adjustment for age, these outcomes were similar between groups. Further adjustment for CVD and HIV-related factors did not alter the findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Neither HIV nor ART was associated with CIMT or carotid distensibility in this urban African population. Longitudinal studies are needed to fully understand the relationship between HIV and CVD across different populations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12977-019-0497-7","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T05:00:01Z","timestamp":1576472401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-6223","authenticated-orcid":false,"given":"Alinda G.","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klariska","family":"Hoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos E.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Peper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Moorhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem D. F.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E.","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel L.","family":"Bots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Klipstein-Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"issue":"2","key":"497_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","volume":"71","author":"RA Legarth","year":"2016","unstructured":"Legarth RA, Ahlstrom MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr. 2016;71(2):213\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"497_CR2","doi-asserted-by":"publisher","first-page":"e642","DOI":"10.1016\/S2214-109X(16)30113-9","volume":"4","author":"V Pillay-van Wyk","year":"2016","unstructured":"Pillay-van Wyk V, Msemburi W, Laubscher R, Dorrington RE, Groenewald P, Glass T, et al. Mortality trends and differentials in South Africa from 1997 to 2012: second National Burden of Disease Study. Lancet Glob Health. 2016;4(9):e642\u201353.","journal-title":"Lancet Glob Health"},{"key":"497_CR3","unstructured":"Stats SA. Mortality and causes of death in South Africa, 2016: Findings from death notification. Statistical release P0309.3; 2018."},{"key":"497_CR4","unstructured":"Massyn N, Padarath A, Peer N, Day C. District Health Barometer 2016\/17. Health Systems Trust; 2017(ISBN: 978-1-919839-92-9)."},{"issue":"7","key":"497_CR5","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","volume":"92","author":"VA Triant","year":"2007","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"497_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614\u201322.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"497_CR7","first-page":"298","volume":"26","author":"F Miedema","year":"2013","unstructured":"Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, de Boer RJ, Borghans JA. Immune activation and collateral damage in AIDS pathogenesis. Front Immunol. 2013;26(4):298.","journal-title":"Front Immunol"},{"issue":"10","key":"497_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/QAD.0000000000001109","volume":"30","author":"E Nou","year":"2016","unstructured":"Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS. 2016;30(10):1495\u2013509.","journal-title":"AIDS"},{"issue":"6","key":"497_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.eimc.2018.09.015","volume":"37","author":"H Knobel","year":"2019","unstructured":"Knobel H, Domingo P, Suarez-Lozano I, Gutierrez F, Estrada V, Palacios R, et al. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain. Enferm Infecc Microbiol Clin. 2019;37(6):373\u20139.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"497_CR10","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS DATA 2017. UNAIDS\/JC2910E; 2017."},{"issue":"3 Suppl","key":"497_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1521\/aeap.2009.21.3_supp.3","volume":"21","author":"DJ Vidrine","year":"2009","unstructured":"Vidrine DJ. Cigarette smoking and HIV\/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Educ Prev. 2009;21(3 Suppl):3\u201313.","journal-title":"AIDS Educ Prev"},{"issue":"5","key":"497_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M14-0954","volume":"162","author":"R Mdodo","year":"2015","unstructured":"Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335\u201344.","journal-title":"Ann Intern Med"},{"issue":"11","key":"497_CR13","doi-asserted-by":"publisher","first-page":"858","DOI":"10.7196\/SAMJ.7388","volume":"103","author":"P Waweru","year":"2013","unstructured":"Waweru P, Anderson R, Steel H, Venter WD, Murdoch D, Feldman C. The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa. S Afr Med J. 2013;103(11):858\u201360.","journal-title":"S Afr Med J"},{"key":"497_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12889-015-1467-1","volume":"15","author":"SJ Clark","year":"2015","unstructured":"Clark SJ, Gomez-Olive FX, Houle B, Thorogood M, Klipstein-Grobusch K, Angotti N, et al. Cardiometabolic disease risk and HIV status in rural South Africa: establishing a baseline. BMC Public Health. 2015;15:135.","journal-title":"BMC Public Health"},{"issue":"1","key":"497_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12889-017-4117-y","volume":"17","author":"TA Gaziano","year":"2017","unstructured":"Gaziano TA, Abrahams-Gessel S, Gomez-Olive FX, Wade A, Crowther NJ, Alam S, et al. Cardiometabolic risk in a population of older adults with multiple co-morbidities in rural south africa: the HAALSI (Health and Aging in Africa: longitudinal studies of INDEPTH communities) study. BMC Public Health. 2017;17(1):206.","journal-title":"BMC Public Health"},{"issue":"9","key":"497_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/hiv.12257","volume":"16","author":"S Hattab","year":"2015","unstructured":"Hattab S, Guiguet M, Carcelain G, Fourati S, Guihot A, Autran B, et al. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2\u00a0years of effective first-line combination antiretroviral therapy. HIV Med. 2015;16(9):553\u201362.","journal-title":"HIV Med"},{"issue":"1","key":"497_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QAI.0000000000000549","volume":"69","author":"BJ Rudy","year":"2015","unstructured":"Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, et al. Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061. J Acquir Immune Defic Syndr. 2015;69(1):52\u201360.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"497_CR18","doi-asserted-by":"publisher","first-page":"e0179994","DOI":"10.1371\/journal.pone.0179994","volume":"12","author":"M Mosepele","year":"2017","unstructured":"Mosepele M, Hemphill LC, Moloi W, Moyo S, Nkele I, Makhema J, et al. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls. PLoS ONE. 2017;12(6):e0179994.","journal-title":"PLoS ONE"},{"issue":"13","key":"497_CR19","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.jbiomech.2016.05.018","volume":"49","author":"RL Gleason Jr","year":"2016","unstructured":"Gleason RL Jr, Caulk AW, Seifu D, Rosebush JC, Shapiro AM, Schwartz MH, et al. Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia. J Biomech. 2016;49(13):2584\u201392.","journal-title":"J Biomech"},{"issue":"11","key":"497_CR20","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1097\/QAD.0b013e328360e9fb","volume":"27","author":"SM Graham","year":"2013","unstructured":"Graham SM, Rajwans N, Jaoko W, Estambale BB, McClelland RS, Overbaugh J, et al. Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression. AIDS. 2013;27(11):1803\u201313.","journal-title":"AIDS"},{"issue":"3","key":"497_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5830\/CVJA-2018-003","volume":"29","author":"M Mosepele","year":"2018","unstructured":"Mosepele M, Mohammed T, Mupfumi L, Moyo S, Bennett K, Lockman S, et al. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana. Cardiovasc J Afr. 2018;29(3):155\u201361.","journal-title":"Cardiovasc J Afr"},{"issue":"11","key":"497_CR22","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/2047487314547656","volume":"22","author":"MO Owolabi","year":"2015","unstructured":"Owolabi MO, Agunloye AM, Umeh EO, Akpa OM. Can common carotid intima media thickness serve as an indicator of both cardiovascular phenotype and risk among black Africans? Eur J Prev Cardiol. 2015;22(11):1442\u201351.","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"497_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.105.579342","volume":"113","author":"T Willum-Hansen","year":"2006","unstructured":"Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113(5):664\u201370.","journal-title":"Circulation"},{"issue":"3","key":"497_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","volume":"66","author":"RR Townsend","year":"2015","unstructured":"Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66(3):698\u2013722.","journal-title":"Hypertension"},{"key":"497_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1902824","volume":"381","author":"WDF Venter","year":"2019","unstructured":"Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381:803\u201315.","journal-title":"N Engl J Med"},{"issue":"2","key":"497_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/QAI.0000000000001908","volume":"80","author":"WDF Venter","year":"2019","unstructured":"Venter WDF, Kambugu A, Chersich MF, Becker S, Hill A, Arulappan N, et al. Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96\u00a0weeks: a multi-country randomised, non-inferiority trial. J Acquir Immune Defic Syndr. 2019;80(2):224\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"497_CR27","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S2352-3018(19)30081-5","volume":"6","author":"WDF Venter","year":"2019","unstructured":"Venter WDF, Moorhouse M, Sokhela S, Serenata C, Akpomiemie G, Qavi A, et al. Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. Lancet HIV. 2019;6(7):e428\u201337.","journal-title":"Lancet HIV."},{"key":"497_CR28","unstructured":"Department of Health South Africa. National hiv testing services: policy; 2016:https:\/\/sahivsoc.org\/Files\/HTS%20Policy%2028%20July%20final%20copy.pdf. Accessed 27 Nov 2019."},{"key":"497_CR29","unstructured":"World Health Organisation. WHO STEPS Instrument (Core and Expanded). Version 3.2. https:\/\/www.who.int\/ncds\/surveillance\/steps\/instrument\/en\/. Accessed 07 Dec 2018."},{"issue":"8","key":"497_CR30","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"497_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4103\/0366-6999.173500","volume":"129","author":"ML Bots","year":"2016","unstructured":"Bots ML, Evans GW, Tegeler CH, Meijer R. Carotid Intima-media Thickness Measurements: relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl). 2016;129(2):215\u201326.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"497_CR32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1177\/2047487317702039","volume":"24","author":"A Vos","year":"2017","unstructured":"Vos A, Tempelman H, Deville W, Barth R, Wensing A, Kretzschmar M, et al. HIV and risk of cardiovascular disease in sub-Saharan Africa: rationale and design of the Ndlovu Cohort Study. Eur J Prev Cardiol. 2017;24(10):1043\u201350.","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"497_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.amjcard.2015.12.062","volume":"117","author":"NM Boulos","year":"2016","unstructured":"Boulos NM, Gardin JM, Malik S, Postley J, Wong ND. Carotid plaque characterization, stenosis, and intima-media thickness according to age and gender in a large registry cohort. Am J Cardiol. 2016;117(7):1185\u201391.","journal-title":"Am J Cardiol"},{"issue":"7","key":"497_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0002-9149(94)90311-5","volume":"74","author":"SG Lage","year":"1994","unstructured":"Lage SG, Kopel L, Monachini MC, Medeiros CJ, Pileggi F, Polak JF, et al. Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;74(7):691\u20135.","journal-title":"Am J Cardiol"},{"issue":"2","key":"497_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/QAI.0b013e31819367cd","volume":"50","author":"MG van Vonderen","year":"2009","unstructured":"van Vonderen MG, Smulders YM, Stehouwer CD, Danner SA, Gundy CM, Vos F, et al. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr. 2009;50(2):153\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"497_CR36","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1161\/STROKEAHA.110.583856","volume":"41","author":"EC Seaberg","year":"2010","unstructured":"Seaberg EC, Benning L, Sharrett AR, Lazar JM, Hodis HN, Mack WJ, et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke. 2010;41(10):2163\u201370.","journal-title":"Stroke"},{"issue":"48","key":"497_CR37","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1093\/eurheartj\/ehv702","volume":"37","author":"NS Idris","year":"2016","unstructured":"Idris NS, Grobbee DE, Burgner D, Cheung MM, Kurniati N, Uiterwaal CS. Effects of paediatric HIV infection on childhood vasculature. Eur Heart J. 2016;37(48):3610\u20136.","journal-title":"Eur Heart J"},{"issue":"14","key":"497_CR38","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/QAD.0b013e32832d3b85","volume":"23","author":"C Grunfeld","year":"2009","unstructured":"Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, Biggs ML, et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS. 2009;23(14):1841\u20139.","journal-title":"AIDS"},{"issue":"5","key":"497_CR39","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.amjcard.2011.10.036","volume":"109","author":"PY Hsue","year":"2012","unstructured":"Hsue PY, Ordovas K, Lee T, Reddy G, Gotway M, Schnell A, et al. Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium. Am J Cardiol. 2012;109(5):742\u20137.","journal-title":"Am J Cardiol"},{"issue":"2","key":"497_CR40","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.atherosclerosis.2006.12.022","volume":"196","author":"MW Lorenz","year":"2008","unstructured":"Lorenz MW, Stephan C, Harmjanz A, Staszewski S, Buehler A, Bickel M, et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis. 2008;196(2):720\u20136.","journal-title":"Atherosclerosis"},{"issue":"1","key":"497_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S2055-6640(20)30237-5","volume":"4","author":"PK Gupta","year":"2018","unstructured":"Gupta PK, Gupta M, Lal AK, Taneja A, Taneja RS, Rewari BB. Markers of subclinical atherosclerotic disease in HIV-infected individuals. J Virus Erad. 2018;4(1):21\u20135.","journal-title":"J Virus Erad"},{"issue":"11","key":"497_CR42","doi-asserted-by":"publisher","first-page":"e113876","DOI":"10.1371\/journal.pone.0113876","volume":"9","author":"A Boyd","year":"2014","unstructured":"Boyd A, Meynard JL, Morand-Joubert L, Michon A, Boccara F, Bastard JP, et al. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection. PLoS ONE. 2014;9(11):e113876.","journal-title":"PLoS ONE"},{"issue":"9","key":"497_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","volume":"19","author":"JS Currier","year":"2005","unstructured":"Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, et al. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005;19(9):927\u201333.","journal-title":"AIDS"},{"issue":"7","key":"497_CR44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3851\/IMP2651","volume":"18","author":"CO Hileman","year":"2013","unstructured":"Hileman CO, Carman TL, Longenecker CT, Labbato DE, Storer NJ, White CA, et al. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study. Antivir Ther. 2013;18(7):921\u20139.","journal-title":"Antivir Ther"},{"key":"497_CR45","doi-asserted-by":"publisher","unstructured":"Kirichenko TV, Myasoedova VA, Shimonova TE, Melnichenko AA, Sviridov D, Sobenin IA, et al. Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection. Biosci Rep; 2018 18;38(4). https:\/\/doi.org\/10.1042\/bsr20180597. Accessed 31 Aug 2018.","DOI":"10.1042\/bsr20180597"},{"issue":"1","key":"497_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2015.03.015","volume":"240","author":"CM Fourie","year":"2015","unstructured":"Fourie CM, Schutte AE, Smith W, Kruger A, van Rooyen JM. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans. Atherosclerosis. 2015;240(1):154\u201360.","journal-title":"Atherosclerosis"},{"issue":"14","key":"497_CR47","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/QAD.0b013e32833d2132","volume":"24","author":"JA Delaney","year":"2010","unstructured":"Delaney JA, Scherzer R, Biggs ML, Shliplak MG, Polak JF, Currier JS, et al. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS. 2010;24(14):2201\u20139.","journal-title":"AIDS"},{"issue":"14","key":"497_CR48","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/QAD.0000000000000762","volume":"29","author":"JH Stein","year":"2015","unstructured":"Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, et al. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS. 2015;29(14):1775\u201383.","journal-title":"AIDS"},{"issue":"4","key":"497_CR49","doi-asserted-by":"publisher","first-page":"e0117125","DOI":"10.1371\/journal.pone.0117125","volume":"10","author":"RL Gleason Jr","year":"2015","unstructured":"Gleason RL Jr, Caulk AW, Seifu D, Parker I, Vidakovic B, Getenet H, et al. Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV\/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia. PLoS ONE. 2015;10(4):e0117125.","journal-title":"PLoS ONE"},{"issue":"10","key":"497_CR50","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cid\/civ586","volume":"61","author":"AF Schoffelen","year":"2015","unstructured":"Schoffelen AF, de Groot E, Tempelman HA, Visseren FL, Hoepelman AI, Barth RE. Carotid intima media thickness in mainly female HIV-infected subjects in rural South Africa: association With cardiovascular but not HIV-related factors. Clin Infect Dis. 2015;61(10):1606\u201314.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"497_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/ofid\/ofw032","volume":"3","author":"MJ Siedner","year":"2016","unstructured":"Siedner MJ. START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2016;3(1):32.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"497_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cid\/ciw261","volume":"63","author":"DB Hanna","year":"2016","unstructured":"Hanna DB, Guo M, Buzkova P, Miller TL, Post WS, Stein JH, et al. HIV infection and carotid artery intima-media thickness: pooled analyses across 5 cohorts of the NHLBI HIV-CVD collaborative. Clin Infect Dis. 2016;63(2):249\u201356.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"497_CR53","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/QAD.0b013e328347f9d4","volume":"25","author":"CW Wester","year":"2011","unstructured":"Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, et al. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS. 2011;25(12):1471\u20139.","journal-title":"AIDS"},{"issue":"4","key":"497_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1212\/WNL.0000000000002278","volume":"86","author":"LA Benjamin","year":"2016","unstructured":"Benjamin LA, Corbett EL, Connor MD, Mzinganjira H, Kampondeni S, Choko A, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: a case-control study. Neurology. 2016;86(4):324\u201333.","journal-title":"Neurology"},{"issue":"5","key":"497_CR55","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1016\/S2214-109X(13)70068-8","volume":"1","author":"RW Walker","year":"2013","unstructured":"Walker RW, Jusabani A, Aris E, Gray WK, Unwin N, Swai M, et al. Stroke risk factors in an incident population in urban and rural Tanzania: a prospective, community-based, case-control study. Lancet Glob Health. 2013;1(5):e282\u20138.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"497_CR56","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV. Circulation. 2018;138(11):1100\u201312.","journal-title":"Circulation"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-019-0497-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-019-0497-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-019-0497-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T19:44:10Z","timestamp":1606851850000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-019-0497-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1186\/s12977-019-0497-7","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"10 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Human Ethics Research Committee of the University of the Witwatersrand (ethics clearance number M160130) and performed conform the Declaration of Helsinki. All participants provided written, informed consent prior to participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}